【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 12
1.1 List of Tables 18
1.2 List of Figures 22
2 Introduction 23
2.1 Catalyst 23
2.2 Related Reports 24
2.3 Upcoming Related Reports 24
3 Disease Overview 25
3.1 Etiology and Pathophysiology 25
3.1.1 Etiology 25
3.1.2 Pathophysiology 27
3.1.3 Classification and Prognosis 28
3.2 Symptoms 30
4 Epidemiology 32
4.1 Disease Background 32
4.2 Risk Factors and Comorbidities 33
4.3 Global Trends 35
4.4 Forecast Methodology 36
4.4.1 Sources Used 38
4.4.2 Sources Not Used 44
4.4.3 Diagnosed Incident Cases of HSCTs 45
4.4.4 Diagnosed Incident Cases of Autologous HSCTs 47
4.4.5 Diagnosed Incident Cases of Allogeneic HSCTs 48
4.4.6 Diagnosed Incident Cases of aGVHD 49
4.4.7 Four-Year Diagnosed Prevalent Cases of aGVHD 49
4.4.8 Diagnosed Incident Cases of cGVHD 50
4.4.9 Five-Year Diagnosed Prevalent Cases of cGVHD 50
4.5 Epidemiological Forecast for GVHD (2013-2023) 51
4.5.1 Diagnosed Incident Cases of HSCTs 51
4.5.2 Diagnosed Incident Cases of Autologous HSCTs 53
4.5.3 Diagnosed Incident Cases of Allogeneic HSCTs 54
4.5.4 Diagnosed Incident Cases of aGVHD 56
4.5.5 Four-Year Diagnosed Prevalent Cases of aGVHD 58
4.5.6 Diagnosed Incident Cases of cGVHD 60
4.5.7 Five-Year Diagnosed Prevalent Cases of cGVHD 61
4.6 Discussion 63
4.6.1 Epidemiological Forecast Insight 63
4.6.2 Limitations of the Analysis 64
4.6.3 Strengths of the Analysis 65
5 Current Treatment Options 66
5.1 Overview 66
5.2 Product Profiles – Major Therapies 68
5.2.1 Methylprednisolone (numerous brand and generic names) 68
5.2.2 Cyclosporine (numerous brands and generic names) 72
5.2.3 Anti-Thymocyte Globulin (ATG) Therapies 77
5.3 Product Profiles – Off-Label Therapies 82
5.3.1 Biologics (Tumor Necrosis Factor (TNF)α Inhibitors, Interleukin-2 Receptor α (CD25) Inhibitors, Co-Stimulatory Blockers and Other Biologics) 82
5.3.2 Small Immunosuppressive Molecules (mTOR Inhibitors, Solid Organ Transplant Therapies, and Anti-Neoplastic Therapies) 101
6 Unmet Need and Opportunity 116
6.1 Overview 116
6.2 Lack of Randomized Clinical Trials 119
6.2.1 Unmet Need 119
6.2.2 Gap Analysis 119
6.2.3 Opportunity 120
6.3 No Consensus Regarding Clinical Trial Endpoints 120
6.3.1 Unmet Need 120
6.3.2 Gap Analysis 120
6.3.3 Opportunity 121
6.4 Optimization of Prophylactic Measures 121
6.4.1 Unmet Need 121
6.4.2 Gap Analysis 122
6.4.3 Opportunity 122
6.5 Lack of Standardized Protocols for Established and Off-Label Therapies 123
6.5.1 Unmet Need 123
6.5.2 Gap Analysis 123
6.5.3 Opportunity 124
6.6 Improved Treatment Outcomes for Patients Who Develop Toxicities 124
6.6.1 Unmet Need 124
6.6.2 Gap Analysis 125
6.6.3 Opportunity 125
6.7 Desire for Treatments that Exhibit Longer-Lasting Efficacy Profiles 125
6.7.1 Unmet Need 125
6.7.2 Gap Analysis 126
6.7.3 Opportunity 127
6.8 Management of SR-aGVHD Patients 127
6.8.1 Unmet Need 127
6.8.2 Gap Analysis 128
6.8.3 Opportunity 128
6.9 Management of Sclerotic cGVHD Patients 128
6.9.1 Unmet Need 128
6.9.2 Gap Analysis 129
6.9.3 Opportunity 129
6.10 Improved Prognosis for Patients with Lung Involvement 130
6.10.1 Unmet Need 130
6.10.2 Gap Analysis 130
6.10.3 Opportunity 131
7 Research and Development Strategies 132
7.1 Overview 132
7.1.1 Improvement of Prophylactic Regimens 132
7.1.2 Inhibition of T-Cell Proliferation and Activation 133
7.1.3 Adopting Treatments from Hematologic Indications 134
7.1.4 Targeting Niche Subgroups Within GVHD 135
7.2 Current Clinical Trial Design 136
7.2.1 Current Trial Designs are Dependent on the Stage Within the Treatment Algorithm That a Product is Targeting 136
7.2.2 Lack of Consensus on Clinical Endpoints in Current Trial Designs 137
7.2.3 Patient Exclusion Issues in Current Trial Designs 137
7.2.4 Current Trial Design of Key Pipeline Products 137
7.3 Future Clinical Trial Design 139
7.3.1 Future Trial Designs Need to Incorporate Randomization 139
7.3.2 Future Trial Designs Need to Incorporate Conditioning Regimens and Hematological Patients 140
7.3.3 Companies Behind Off-Label Therapies Should Strategize to Conduct Randomized Studies 140
7.3.4 Design of Early-Phase Clinical Trials for Cellular and Gene Therapy Products Accommodates 2014 Guidance from the FDA 140
8 Pipeline Assessment 141
8.1 Overview 141
8.2 Promising Drugs in Clinical Development 142
8.2.1 Leukotac (inolimomab) 142
8.2.2 Begedina (BT 5/9) 147
8.2.3 Budenofalk (budesonide) 150
8.2.4 ATG-Fresenius (EZ-2053) 153
8.2.5 Prochymal (remestemcel-L) 156
8.2.6 MultiStem (modified mesenchymal stem cells) 161
8.2.7 Uvadex (Extracorporeal Photophoresis) 164
8.2.8 orBec (beclomethasone dipropionate) 168
8.3 Innovative Early-Stage Approaches 171
8.3.1 Targeting Regulatory T Cells 174
8.3.2 Mesenchymal Stem Cell Therapies 175
8.3.3 Immunomodulatory Cell Surface Receptor Inhibitors 176
8.3.4 IL-6 Inhibitors 177
9 Pipeline and Off-Label Valuation Analysis 178
9.1 Clinical Benchmarking of Key Pipeline and Off-Label Drugs 178
9.1.1 GVHD Prophylaxis 178
9.1.2 Acute GVHD 181
9.1.3 Chronic GVHD 185
9.2 Commercial Benchmarking of Key Pipeline and Off-Label Drugs 186
9.2.1 GVHD Prophylaxis 187
9.2.2 Acute GVHD 189
9.2.3 Chronic GVHD 191
9.3 Competitive Assessment 193
9.3.1 GVHD Prophylaxis 193
9.3.2 Acute GVHD 194
9.3.3 Chronic GVHD 196
9.4 Top-Line Five-Year Forecast 198
9.4.1 US 203
9.4.2 5EU 207
10 Appendix 211
10.1 Bibliography 211
10.2 Abbreviations 230
10.3 Methodology 236
10.4 Forecasting Methodology 236
10.4.1 Diagnosed GVHD Patients 236
10.4.2 Percent Drug-Treated Patients 237
10.4.3 Drugs Included in Each Therapeutic Class 237
10.4.4 Launch and Patent Expiry Dates 238
10.4.5 General Pricing Assumptions 238
10.4.6 Individual Drug Assumptions 239
10.4.7 Generic Erosion 246
10.4.8 Pricing of Pipeline Agents 246
10.5 Physicians and Specialists Included in This Study 247
10.6 About the Authors 249
10.6.1 Author 249
10.6.2 Reviewer 249
10.6.3 Epidemiologist 250
10.6.4 Global Head of Healthcare 250
10.7 About GlobalData 251
10.8 Disclaimer 251
【レポート販売概要】
■ タイトル：世界の移植片対宿主病治療薬市場■ 英文：OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018
■ 発行日：2014年8月20日
■ 調査会社：GlobalData
■ 商品コード：GDHC021POA
■ 調査対象地域：グローバル
- 世界の調達アウトソーシング市場動向（2012-2016）TechNavio's analysts forecast the Global Procurement Outsourcing market to grow at a CAGR of 23.14 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant cost reduction. The Global Procurement Outsourcing market has also been witnessing the changing pricing models. However, the lack of domain understanding could pose a challenge to the growt …
- 世界の在庫管理システム市場動向（2012-2016）TechNavio's analysts forecast the Global Warehouse Management System (WMS) market to grow at a CAGR of 16.15 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need for companies to reduce their overall cost. The Global Warehouse Management Software market has also been witnessing the emergence of software-as-a-service (SaaS) based solutions. Howeve …
- スパンメル不織布の世界市場展望2017-20276According to Stratistics MRC, the Global Spunmelt Non-woven Fabrics Market is accounted for $22.30 billion in 2017 and is expected to reach $47.48 billion by 2026 growing at a CAGR of 8.7% during the forecast period. Some of the key factors influencing the market are growth of modern healthcare in developing markets, rise in the birth rate in emerging economies and increase in geriatric population …
- エチレングリコールの世界市場：モノエチレングリコール（MEG）、ジエチレングリコール（DEG）、トリエチレングリコール（TEG）About Ethylene Glycol Ethylene glycol is a versatile organic compound which has properties such as clarity and viscosity. It acts as a hydroscopic liquid at room temperature. It is used in polyester films, fibers, and PET resin that are used for packaging, as well as a raw material in antifreeze coolants. MEG is the most important type of ethylene glycol, which is used in fibers, films, and bottle …
- 天然ガスの世界市場：リソースの種類別、地域別Global Natural Gas Market: About this market Technavio’s natural gas market analysis considers sales from conventional and unconventional resource types. Our study also finds the sales of natural gas in APAC, Europe, MEA, North America, and South America. In 2019, the conventional segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such …
- 世界におけるCCTVビデオ監視システム市場（2014-2024）Surveillance technologies now consistently feature as an essential component of every national government’s effort to deter criminal activity and investigate those offences that do occur, in addition to playing an important role in the development of an effective homeland security posture. Additionally, they also provide private consumers with an effective, and relatively inexpensive, means of ens …
- 感圧接着剤の世界市場：水性感圧接着剤、溶剤型感圧接着剤、ホットメルト感圧接着剤、放射線感圧接着剤Pressure sensitive adhesives (PSA) are non-metallic materials used to bond different materials, mainly on their surface, through adhesion and cohesion. Water, or heat is not required to apply the adhesive. The adhesives occupy the largest market share in the adhesives business. They are either permanent or removable and can match with a variety of substrates. The major materials used in formulatin …
- 世界の脳深部刺激装置市場動向（2012-2016）TechNavio’s analysts forecast the Global Deep Brain Stimulator market to grow at a CAGR of 16.99 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rapidly increasing awareness about deep brain stimulation devices in the US. The Global Deep Brain Stimulator market has also been witnessing the emergence of less invasive and non-invasive treatments. H …
- ガス衣類乾燥機の世界市場2016-2020About Gas Dryers Gas dryers have emerged as a major home appliance as they offer a faster drying cycle compared to outdoor drying on clotheslines. They can be used irrespective of the weather conditions and are increasingly being purchased along with washing machines. Increased awareness about the benefits of gas dryers is driving the global gas dryer market for the residential segment. Technavio’ …
- 世界の農業用ロボット市場：提供別、種類別（UAV、搾乳ロボット、ドライバーレストラクター、自動収穫システム）、農業環境別、農産物別、用途別（収穫管理、フィールドファーミング）、地域別“The agricultural robots market is projected to grow at a CAGR of 22.8% during 2019–2024” The agricultural robots market is expected to grow from USD 7.4 billion in 2020 and is projected to reach USD 20.6 billion by 2025; it is expected to grow at a CAGR of 22.8% during the forecast period. A shortage of new farmers, as indicated by the rising average age of farmers is driving the further use of a …
- 世界の女性衛生用品市場動向（2014年4月）：ニュース・イベントSynopsis Using this report, marketers will effectively gain an insight into the latest happenings in the global feminine hygiene market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global feminine hygiene market on a monthly basis. Scope The report provides a review of the latest news and key events in …
- 自動力率制御装置（APFC）の世界市場予測（～2022年）：リレー、コンデンサ、ディスプレイ、マイクロコントローラ、スイッチ、レジスターThe global automatic power factor controller market is estimated to grow at a CAGR of 4.6% and is expected to be valued at USD 4.78 Billion by 2022. APFCs help in lower the power consumption due to the presence of non-linear loads such as transformers, motors, and other machines in industries. Also, the growing demand for APFCs in the utility and manufacturing industries to improve the reactive po …
- 航空宇宙産業向け風洞試験の世界市場2018-2022100 Pages, November 2018 About this market The growing need for achieving low-noise and emission-free air travel has seen a rise in electrifying aircraft propulsion systems. Hence, the increasing use of virtual system models for optimizing drives, developing electrical networks, environmental control systems (ECS), reliable fuel systems control, and sensor technology as well as other subsystems an …
- 低電圧MOSFETのグローバル市場動向（2014-2018）About Low-voltage MOSFETs A MOSFET is a three terminal semiconductor component and a type of transistor which is used for amplifying electronic signals or switching electronic signals. MOSFETs are mainly used for voltage conversions. MOSFETs are basically silicon-based semiconductor components used in electronic devices. Further, MOSFETs have three terminals namely source, gate, and drain. A low-v …
- モバイルアプリテストサービスの世界市場2017-2021About Mobile Application Testing (MAT) Services Software testers face many challenges while developing innovative and error-free software products and applications. They require IT solutions that can minimize the cost of testing services and enhance the quality of software. Rapid changes in technology and increasing mobility solutions compel software developers to consider testing as an important …
